Dr Rogelio Solano Pérez

Dr Rogelio Solano Pérez
Ortopedia Mixta y Cirugía de Columna

sábado, 10 de mayo de 2014

A brave Asturian, cavo varus foot by spina bifida

http://www.drfernandonoriega.com/361/a-brave-asturian-cavo-varus-foot-by-spina-bifida/?utm_source=rss&utm_medium=rss&utm_campaign=a-brave-asturian-cavo-varus-foot-by-spina-bifida


A brave Asturian, cavo varus foot by spina bifida

She was determined to solve the problem of her left foot, after so many neurological controls anyone knew about the possibility of reconstructing her feet in order to improve her walking ability.
MARTA2-300x262MARTA1-286x300Frequent falls, lack of stability was a constant in her everyday life. She decided to be operated and they practiced metatarsal’s osteotomies yet it did not solved the problem, It made it even worse.
She visited the IICOP and I explored her feet, finding a lack of functionality of the anterior tibial muscle, a shortening of the Achilles tendon as well as a cavo varus foot deformity. The gait was typical of this sort patients, as you can watch in the video below.
She went back to her home town and told everyone what she had experienced in Madrid.The neurologist transmit her an utterly feeling of disbelief when he was hearing about foot reconstruction techniques.
Nonetheless she was decisive, she wanted us to operate on her neurological foot caused by spina bifida.
MARTA6-300x240Last october we made a full correction of her left foot, both a lengthening of the muscles and a transplant of the posterior tibial tendon to the lift of the foot were done. The hinfoot bones wMARTA5-300x295ere aligned and finally clawtoes were repaired. There was no need in strengthening the calf muscles.
She came back to the IICOP a few months after surgery. She was very happy that she could walk normally even she asked if she could wear high heels and the answer was:“YES, WHY NOT?”
The neurologist was shocked when he saw the foot correction. Now the patient have a normal life she is able to walk again without pain, using normal shoes.
I think is the responsibility of many neurologists or rehabilitation doctors(hopefully one of them read me) to stay tuned for their patients and have a duty to know that neurological feet can be rebuilt and this return the patient the ability to have a better life.

MARCHA EN ESPINA BIFIDA Y SIRINGOMIELIA

http://youtu.be/26T_AqCWtUs 

 


jueves, 8 de mayo de 2014

Driving ability hampered by dominant arm immobilization

http://www.healio.com/orthopedics/arthroscopy/news/online/%7B9fff9034-553b-4fc6-8c90-2004eed40e8e%7D/driving-ability-hampered-by-dominant-arm-immobilization



Driving ability hampered by dominant arm immobilization

HOLLYWOOD, Fla. — Driving ability was more profoundly impaired in patients who had surgery on their dominant driving arm than patients who had surgery on their non-dominant arm, according to a study presented at the Arthroscopy Association of North America Annual Meeting. Read more
“Although shoulder arthroscopic repairs may not adversely standard driving conditions, they certainly limited the ability to perform evasive maneuvers under hazardous conditions,” Jazrawi said. – by Christian Ingram
Reference:
Jazrawi LM. Paper #SS-21. Presented at: Arthroscopy Association of North America Annual Meeting; May 1-3, 2014; Hollywood, Fla.
Disclosure: Jazrawi has no relevant financial disclosures.

martes, 29 de abril de 2014

Una técnica novedosa confirma la eficacia sintomática del condroitín sulfato en artrosis

http://www.condroprotectores.es/una-tecnica-novedosa-confirma-la-eficacia-sintomatica-del-condroitin-sulfato-en-artrosis/


Una técnica novedosa confirma la eficacia sintomática del condroitín sulfato en artrosis

Un estudio realizado por el Servicio de Reumatología y Neuroimagen del Hospital del Mar de Barcelona, en colaboración con la compañía española Bioibérica Farma, ha demostrado, mediante una novedosa técnica de análisis de la respuesta cerebral al dolor, la eficacia del condroitín sulfato en el tratamiento sintomático de la artrosis.
Metodología
Fuente: Hospital del Mar
Fuente: Hospital del Mar
Se trata de un ensayo clínico en fase IV, aleatorizado, doble ciego y controlado con placebo, realizado en un total de 64 pacientes con artrosis de rodilla que recibieron 800 mg al día de condroitín sulfato o placebo. El procedimiento consistió en aplicar un estímulo doloroso a los participantes, provocado por la presión en la rótula (una maniobra con repercusión directa sobre el cartílago) y ver su respuesta cerebral con resonancia magnética funcional.
La medida principal de eficacia fue la disminución de la señal cerebral en respuesta al estímulo doloroso. Así, los pacientes artrósicos que recibieron condroitín sulfato experimentaron una mayor reducción de la activación cerebral en respuesta al dolor provocado por la presión en la rótula en diversas regiones cerebrales.
Conclusiones
Los pacientes artrósicos que recibieron condroitín sulfato experimentaron una mayor reducción de la activación cerebral en respuesta al dolor provocado. “Es importante remarcar que el efecto del condroitín sulfato se ha manifestado en la sustancia gris periacueductal y en las áreas motora y somatosensoriales de la corteza cerebral, que son elementos esenciales en la fisiología de la respuesta al dolor“, explica a Europa Press el doctor Jordi Monfort, investigador principal del estudio y reumatólogo del Hospital del Mar de Barcelona.
Un problema inherente a la valoración de la eficacia de un fármaco para el dolor es la falta de objetividad de los instrumentos disponibles para medirlo. En este sentido, añade Monfort, “la resonancia magnética funcional ha demostrado ser una técnica muy prometedora para objetivar los efectos del tratamiento para el dolor en la artrosis“.

martes, 22 de abril de 2014

Discusión entre pares / 50 yr male close fractur what is best management




50 yr male close fractur what is best management